The realistic timeline Based on the current state of the clinical program, regulatory precedent, and publicly available information from Eli Lilly, here is the most realistic projection: Mid to late 2026: Remaining TRIUMPH, TRANSCEND, and SYNERGY Phase 3 results are reported
Why It Matters for Patients Targeting stubborn fat: Belly fat and liver fat are among the most harmful types of fat for long-term health
Im a mere overweight mortal, after all, bombarded by the sneaky advertising that ranges from Instagram ads to celebrity gossip over who might have done what
Potential benefits include additional weight loss in cases of inadequate surgical response or weight regain, enhanced glycemic control for persistent type 2 diabetes, cardiovascular risk reduction in appropriate patients, and improvement in obesity-related comorbidities without requiring revision surgery
Its an amino acid designed to modulate energy metabolism, so energize up with carbohydrates